🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is investigating an intravenous (IV) medication called 9-ING-41 ...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Start Date
2021-09-17
Trial ID
NCT05010629
Treatments Being Tested
The goal of this randomized control trial is to test an intervention design...
Status
Terminated
Location
UPMC/University of Pittsburgh
Start Date
2025-08-04
Trial ID
NCT06501365
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This phase II trial studies how well fludeoxyglucose F 18 (FDG)-labeled pos...
Status
Completed
Location
Harborview Medical Center
Start Date
2007-10
Trial ID
NCT00564733
With improvements in response rate and survival seen for HER2 positive pati...
Status
Terminated
Location
Florida Cancer Specialists - South
Start Date
2013-02
Trial ID
NCT01769508
Treatments Being Tested
This phase II trial is studying how well giving irinotecan together with ci...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-06
Trial ID
NCT00062374
Non-randomized phase I/II, open-labeled clinical study, 1-arm, multicenter,...
Status
Withdrawn
Location
PEYRADE Frédéric
Start Date
2019-03-12
Trial ID
NCT03114280
Treatments Being Tested
RATIONALE: Gathering information over time from laboratory tests, imaging s...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2007-05
Trial ID
NCT00755313
This is a first-in-human study evaluating the anti-T cell immunoglobulin an...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-07-08
Trial ID
NCT02817633
Treatments Being Tested
This study consists of several parts: dose escalation, dose expansion, dose...
Status
Completed
Location
University of California at San Francisco ( Site 0004)
Start Date
2018-07-11
Trial ID
NCT03564691
Treatments Being Tested